Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia.
Avendaño-Solá C, Ramos-Martínez A, Muñez-Rubio E, Ruiz-Antorán B, Malo de Molina R, Torres F, Fernández-Cruz A, Calderón-Parra J, Payares-Herrera C, Díaz de Santiago A, Romera-Martínez I, Pintos I, Lora-Tamayo J, Mancheño-Losa M, Paciello ML, Martínez-González AL, Vidán-Estévez J, Nuñez-Orantos MJ, Saez-Serrano MI, Porras-Leal ML, Jarilla-Fernández MC, Villares P, de Oteyza JP, Ramos-Garrido A, Blanco L, Madrigal-Sánchez ME, Rubio-Batllés M, Velasco-Iglesias A, Paño-Pardo JR, Moreno-Chulilla JA, Muñiz-Díaz E, Casas-Flecha I, Pérez-Olmeda M, García-Pérez J, Alcamí J, Bueno JL, Duarte RF; ConPlas-19 Study Group. Avendaño-Solá C, et al. Among authors: casas flecha i. J Clin Invest. 2021 Oct 15;131(20):e152740. doi: 10.1172/JCI152740. J Clin Invest. 2021. PMID: 34473652 Free PMC article. Clinical Trial.
Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19.
Cerrada-Romero C, Berastegui-Cabrera J, Camacho-Martínez P, Goikoetxea-Aguirre J, Pérez-Palacios P, Santibáñez S, José Blanco-Vidal M, Valiente A, Alba J, Rodríguez-Álvarez R, Pascual Á, Oteo JA, Miguel Cisneros J, Pachón J, Casas-Flecha I, Cordero E, Pozo F, Sánchez-Céspedes J. Cerrada-Romero C, et al. Among authors: casas flecha i. Sci Rep. 2022 May 5;12(1):7397. doi: 10.1038/s41598-022-11439-7. Sci Rep. 2022. PMID: 35513481 Free PMC article.
Granuloma annulare triggered by SARS-CoV-2 infection: Immunohistochemical staining.
Monte-Serrano J, García-Gil MF, García-García M, Casas-Flecha I, Matovelle-Ochoa C, Ara-Martín M. Monte-Serrano J, et al. Among authors: casas flecha i. Dermatol Ther. 2021 May;34(3):e14897. doi: 10.1111/dth.14897. Epub 2021 Mar 3. Dermatol Ther. 2021. PMID: 33599069 Free PMC article. No abstract available.
Absence of SARS-CoV-2 RNA detection in tissue samples of COVID-19-related cutaneous lesions analyzed by real-time RT-PCR.
García-Gil MF, Monte-Serrano J, García García M, Prieto-Torres L, Pascual-Del-Riquelme AJ, Casas Flecha I, Ara-Martín M. García-Gil MF, et al. Among authors: casas flecha i. J Eur Acad Dermatol Venereol. 2021 May;35(5):e318-e321. doi: 10.1111/jdv.17146. Epub 2021 Mar 2. J Eur Acad Dermatol Venereol. 2021. PMID: 33539560 Free PMC article. No abstract available.
[Viral epidemic outbreaks and public health alerts studied at the National Centre of Microbiology during a two-year period (2012-2013].
Echevarría Mayo JM, Avellón Calvo AA, Cabrerizo Sanz M, Casas Flecha I, Echevarría Mayo JE, de Ory Manchón Fde O, Negredo Antón A, Pozo Sánchez F, Sánchez-Seco Fariñas MP, Tarragó Asensio D, Trallero Masó G. Echevarría Mayo JM, et al. Among authors: casas flecha i. Rev Esp Salud Publica. 2016 Mar 23;90:E16. Rev Esp Salud Publica. 2016. PMID: 27007553 Free article. Spanish. No abstract available.
[Influenza virus infections in infants aged less than two years old].
Calvo Rey C, García García ML, Casas Flecha I, Martín del Valle F, Centeno Jiménez M, Pérez-Breña P. Calvo Rey C, et al. An Pediatr (Barc). 2005 Jul;63(1):22-8. doi: 10.1157/13076763. An Pediatr (Barc). 2005. PMID: 15989867 Free article. Spanish.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Kissling E, Hooiveld M, Martínez-Baz I, Mazagatos C, William N, Vilcu AM, Kooijman MN, Ilić M, Domegan L, Machado A, de Lusignan S, Lazar M, Meijer A, Brytting M, Casado I, Larrauri A, Murray JK, Behillil S, de Gier B, Mlinarić I, O'Donnell J, Rodrigues AP, Tsang R, Timnea O, de Lange M, Riess M, Castilla J, Pozo F, Hamilton M, Falchi A, Knol MJ, Kurečić Filipović S, Dunford L, Guiomar R, Cogdale J, Cherciu C, Jansen T, Enkirch T, Basile L, Connell J, Gomez V, Sandonis Martín V, Bacci S, Rose AM, Pastore Celentano L, Valenciano M; I-MOVE-COVID-19 and ECDC primary care study teams; I-MOVE-COVID-19 and ECDC primary care study team (in addition to authors above). Kissling E, et al. Euro Surveill. 2022 May;27(21):2101104. doi: 10.2807/1560-7917.ES.2022.27.21.2101104. Euro Surveill. 2022. PMID: 35620997 Free PMC article.
Epidemiology of the 2009 influenza pandemic in Spain. The Spanish Influenza Surveillance System.
Larrauri Cámara A, Jiménez-Jorge S, Mateo Ontañón Sd, Pozo Sánchez F, Ledesma Moreno J, Casas Flecha I; Spanish Influenza Surveillance System (SISS). Larrauri Cámara A, et al. Among authors: casas flecha i. Enferm Infecc Microbiol Clin. 2012 Oct;30 Suppl 4:2-9. doi: 10.1016/S0213-005X(12)70098-8. Enferm Infecc Microbiol Clin. 2012. PMID: 23116786
15 results